Literature DB >> 32171739

Influence of disulfide bonds in human beta defensin-3 on its strain specific activity against Gram-negative bacteria.

Christian Nehls1, Arne Böhling1, Rainer Podschun2, Sabine Schubert2, Joachim Grötzinger3, Andra Schromm1, Henning Fedders4, Matthias Leippe4, Jürgen Harder5, Yani Kaconis1, Sabine Gronow6, Thomas Gutsmann7.   

Abstract

Antimicrobial peptides (AMPs) play an important role in the host defense against various microbes. One of the most efficient human AMPs is the human beta defensin-3 (hBD-3) which is produced by, e.g. keratinocytes and lung epithelial cells. However, the structure-function relationship for AMPs and in particular for defensins with their typical three disulfide bonds is still poorly understood. In this study the importance of the three disulfide bonds for the activity of the AMPs is investigated with biological assays and with biophysical experiments utilizing different membrane reconstitution systems. The activities of natural hBD-3, hBD-3-c (cyclic variant with one disulfide bond), and hBD-3-l (linear variant without disulfide bonds) and fragments thereof were tested against specific Gram-negative bacteria. Furthermore, hemolytic and cytotoxic activities were analyzed as well as the potency to neutralize immune cell stimulation of lipopolysaccharide (LPS). Experiments using reconstituted lipid matrices composed of phospholipids or LPS purified from the respective Gram-negative bacteria, showed that the membrane activity of all three hBD-3 peptides is decisive for their capability to kill bacteria and to neutralize LPS. In most of the test systems the linear hBD-3-l showed the highest activity. It was also the only peptide significantly active against polymyxin B-resistant Proteus mirabilis R45. However, the stability of hBD-3 against protease activity decreases with decreasing number of disulfide bonds. This study demonstrates that the refining of AMP structures can generate more active compounds against certain strains.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Year:  2020        PMID: 32171739     DOI: 10.1016/j.bbamem.2020.183273

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  4 in total

1.  Measuring Thousands of Single-Vesicle Leakage Events Reveals the Mode of Action of Antimicrobial Peptides.

Authors:  Kareem Al Nahas; Marcus Fletcher; Katharine Hammond; Christian Nehls; Jehangir Cama; Maxim G Ryadnov; Ulrich F Keyser
Journal:  Anal Chem       Date:  2022-06-27       Impact factor: 8.008

Review 2.  Design of Membrane Active Peptides Considering Multi-Objective Optimization for Biomedical Application.

Authors:  Niels Röckendorf; Christian Nehls; Thomas Gutsmann
Journal:  Membranes (Basel)       Date:  2022-02-02

3.  Expression and Functional Characterization of a Novel Antimicrobial Peptide: Human Beta-Defensin 118.

Authors:  Qian Lin; Kunhong Xie; Daiwen Chen; Bing Yu; Xiangbing Mao; Jie Yu; Junqiu Luo; Ping Zheng; Yuheng Luo; Hui Yan; Jun He
Journal:  Biomed Res Int       Date:  2020-11-09       Impact factor: 3.411

4.  Effects of gold nanoparticles combined with human β-defensin 3 on the alveolar bone loss of periodontitis in rat.

Authors:  Jing Zhou; Lingjun Li; Di Cui; Xiaoting Xie; Wenrong Yang; Fuhua Yan
Journal:  Biomed Eng Online       Date:  2021-11-24       Impact factor: 2.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.